KONNANCE
Live / Applied — Fourth extension granted (statement of use) (as of 21 Aug 2025)
What this means for you
Not registered yet, but its 30 Jun 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97482988
- Mark type
- Stylized text
- Filed
- 30 Jun 2022
- Published for opposition
- 27 Jun 2023
- Attorney of record
- Brian J. Focarino
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of neurological and neuro-psychiatric diseases, disorders and conditions; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for treating schizophrenia, major depressive disorder, insomnia, mood disorder, negative symptoms, cognitive disorders, Parkinson's disease; pharmaceutical preparations for blocking serotonin receptors and sigma receptors
Owner
- Minerva Neurosciences, Inc., Burlington, MA, US
- Minerva Neurosciences, Inc., Burlington, MA, US
Prosecution history
- 22 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 22 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Aug 2025 — SOU EXTENSION 4 GRANTED
- 21 Aug 2025 — SOU EXTENSION 4 FILED
- 21 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2025 — SOU EXTENSION 3 GRANTED
- 19 Feb 2025 — SOU EXTENSION 3 FILED
- 19 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jul 2024 — SOU EXTENSION 2 GRANTED
- 16 Jul 2024 — SOU EXTENSION 2 FILED
- 16 Jul 2024 — SOU TEAS EXTENSION RECEIVED
- 11 Jul 2024 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 11 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED